TL;DR
A LASIK price campaign needs an approved definition of what the advertised amount buys, who may receive that offer, what is excluded and how someone obtains an individual explanation. Keep price, financing and clinical suitability separate. Reject the campaign when material inputs are unknown instead of filling them with familiar industry terms.
Ask for the offer before the creative
A low headline amount is incomplete without its unit and scope. Does it describe an evaluation, a procedure, an eye, a package or another actual item? Which provider and location offer it? What happens if the eventual clinically appropriate option differs? Have the commercial and qualified service owners answer from the actual practice arrangement.
This article supplies no fee, discount, financing rate or universal inclusion list. It is an acceptance record for a real proposed offer. Use written approved inputs, leaving unavailable facts blank. Do not infer terms from a competitor's advertisement.
For U.S. advertising, FTC guidance calls for truthful claims supported before an ad runs and considers express claims, implied claims and material omissions. FTC's advertising FAQ. Qualified review must address the actual campaign and applicable jurisdiction; completing a worksheet is not legal clearance.
Complete a price-claim acceptance record
| Offer field | Verified input to obtain | Acceptance question |
|---|---|---|
| Price unit | Actual amount and precisely what unit it describes | Could someone mistake an eye-based amount for a person's complete cost? |
| Included service | Approved description of evaluations, testing, procedure or other included items | Does the headline imply a broader package? |
| Exclusions and separate providers | Actual excluded charges, services and organizations | Are material conditions understandable beside the offer? |
| Eligibility and availability | Real commercial conditions, locations and participating providers | Can staff explain the offer without making a clinical judgment from an ad? |
| Individual cost process | Approved route for an individualized explanation or estimate | Does a visitor know how final terms are established? |
| Financing, if offered | Lender-approved terms and the responsible reviewer | Is a payment illustration being mistaken for the total price? |
| Offer change or ending | Actual approved conditions and earlier-inquiry handling | Can the practice explain which version applies? |
| Final display | Rendered ad, destination and acknowledgement | Does the complete impression match the approved offer? |
Attach the fact owner, evidence reference and approval state to each completed field. Do not put confidential contracts or personal finance information into a general creative brief. The writer needs the approved public wording and its limits.
Separate affordability from suitability
An administrative payment option does not establish whether a person should receive LASIK. Keep clinical evaluation and informed choice outside the price qualification process. A marketing form should not declare eligibility for surgery because someone selects a payment preference.
FDA cautions readers against choosing solely on cost and warns about vision guarantees and package-style advertising. FDA's doctor-selection and advertising guidance. Use that caution when reviewing the impression created by a promotional offer. Do not attach a guaranteed clinical result to a price or treat a refund promise as proof of outcome.
If a price depends on an assessment, ask qualified reviewers whether the headline and condition accurately communicate the real offer. A footer should not be relied upon to repair an invitation that the main message overstates.
Review financing as its own claim
If the practice offers financing, identify who actually provides it and who approves the wording. A monthly payment, amount financed, total cost and advertised procedure price describe different things. Do not let an agency invent an illustration or shorten lender-approved terms for a banner.
Have the responsible legal and commercial reviewers determine the required disclosures and applicable rules. If the actual terms cannot be confirmed, keep financing claims out of the campaign while continuing the rest of the offer review. This record does not provide consumer-credit advice or a template for compliant lending advertising.
Staff also need a response for questions outside their authority. Give them the approved commercial contact route and clinical escalation process instead of asking them to improvise a complete-price or suitability promise.
Accept the complete display and operating response
Read the ad, mobile landing page, call script, reused card, form and acknowledgement together. Highlight every amount, inclusion claim and eligibility phrase. Compare them with the approved record. If a small format cannot preserve the necessary meaning, use narrower wording or another format.
The claim-display guide helps check those variants after the underlying offer is verified. The scope budgeting guide helps establish who pays for creative revisions and ongoing changes. This record's distinct decision is whether the LASIK price proposition is sufficiently defined to advertise.
Finish with accept, revise or hold the specific offer: verified proposition ___; material unresolved term ___; permitted wording ___; responsible reviewer ___; affected surfaces ___; next change trigger ___. Hold an unsupported price claim rather than treating unrelated website work as blocked.
Frequently asked questions
Can we advertise a starting price?
Have the actual amount, availability and material conditions assessed by the responsible reviewers. A familiar label does not establish that the specific presentation is truthful or complete.
Should marketing include every possible clinical scenario?
Keep clinical assessment with qualified staff. The offer must still explain its verified commercial scope and a usable route for individual questions without implying universal eligibility.
Does a disclaimer make a guaranteed result acceptable?
Do not assume that. Require appropriate evidence and qualified review of the complete impression. FDA's caution is a reason to challenge outcome guarantees before approving the creative.